Performance analysis of Avalo Therapeutics (AVTX)
Annual Return
Over the past 3 years, AVTX has had an average annual return of -36.41%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, AVTX has had an average annual return of -70.61%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, AVTX has had an average annual return of -44.74%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Nov 13, 2015, AVTX has had an average annual return of -45.24%, underperforming the benchmark SPY, which returned +14.81% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | +166.67% | -25.00% | -99.24% | -75.29% | -35.61% | -51.02% | +66.87% | +0.94% | +263.47% | -73.72% | -16.25% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -18.75% | +15.38% | -13.33% | -7.69% | +16.67% | +14.29% | +0% | +0% | |||||
| 2025 | +16.67% | -14.29% | +16.67% | -42.86% | -25.00% | +33.33% | +75% | +14.29% | +37.50% | +45.45% | +0% | +0% | +166.67% |
| 2024 | -50.00% | +0% | +375% | -21.05% | -33.33% | +10% | -9.09% | -40.00% | +33.33% | +37.50% | -27.27% | -25.00% | -25.00% |
| 2023 | -21.71% | -36.13% | -30.48% | +66.03% | -1.32% | -87.63% | -43.24% | -50.00% | +19.05% | -8.00% | -34.78% | -46.67% | -99.24% |
| 2022 | -42.19% | -25.68% | -0.77% | -43.32% | -12.37% | +38.89% | -40.00% | +32% | -30.10% | +80.64% | -8.88% | -7.81% | -75.29% |
| 2021 | +19.32% | +6.98% | -10.39% | +3.97% | -15.92% | +23.86% | -18.65% | +16.54% | -29.68% | +7.34% | -14.53% | -15.00% | -35.61% |
| 2020 | -26.72% | -22.78% | -18.69% | -4.44% | +36.29% | -19.50% | +5% | -9.89% | -7.51% | -9.46% | +21.36% | +5.60% | -51.02% |
| 2019 | +60.99% | +37.69% | -18.44% | -6.85% | -10.29% | +11.48% | -25.92% | -19.60% | +1.54% | +4.56% | +9.59% | +42.97% | +66.87% |
| 2018 | +3.44% | +40.79% | -7.94% | -13.29% | +11.56% | +4.58% | +2.30% | +8.78% | -3.31% | -12.21% | -14.39% | -7.98% | +0.94% |
| 2017 | -4.00% | -13.63% | -7.51% | -34.54% | +13.30% | +14.38% | +23.95% | +3.10% | +16.12% | +32.94% | +57.52% | +79.78% | +263.47% |
Drawdown analysis of Avalo Therapeutics (AVTX)
The maximum drawdown for the AVTX was -99.98%, occurring on Jan 17, 2024. This drawdown has not yet recovered.
The current AVTX drawdown is -99.91%.
Since Nov 13, 2015 AVTX has experienced the following drawdowns:
- 50% or more: 3 times
- 40% or more: 4 times
- 30% or more: 5 times
- 20% or more: 5 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.98% | Feb 27, 2019 | 1230 | Jan 17, 2024 | Ongoing | Ongoing | Ongoing |
| -91.55% | Nov 23, 2016 | 105 | Apr 28, 2017 | 215 | Mar 7, 2018 | 320 |
| -60.57% | Mar 17, 2016 | 55 | Jun 6, 2016 | 117 | Nov 18, 2016 | 172 |
| -46.64% | Mar 7, 2018 | 204 | Dec 27, 2018 | 39 | Feb 25, 2019 | 243 |
| -35.56% | Nov 16, 2015 | 51 | Feb 1, 2016 | 31 | Mar 16, 2016 | 82 |